Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Intra-Cellular Therapies Inc. buy RudolfL

Intra-Cellular Therapies Inc.
Start price
€40.53
25.01.22 / 60%
Target price
€65.00
30.01.23
Performance (%)
10.09%
End price
€44.62
20.01.23
Summary
This prediction ended on 20.01.23 with a price of €44.62. The prediction had a final performance of 10.09%. RudolfL has 60% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Intra-Cellular Therapies Inc. - - - -
iShares Core DAX® 0,44 % 5,64 % 7,81 % 63,64 %
iShares Nasdaq 100 1,06 % 0,28 % 27,24 % 88,12 %
iShares Nikkei 225® 1,77 % 0,41 % 49,27 % 83,53 %
iShares S&P 500 0,37 % 1,92 % 22,34 % 68,75 %

Comments by RudolfL for this prediction

In the thread Intra-Cellular Therapies Inc. diskutieren
Prediction Buy
Perf. (%) 10.09%
Target price 48.000
Change
Ends at

Buy mit Kursziel 48,0

RudolfL 
0
Report Share
25.01.22
Prediction Buy
Perf. (%) 10.09%
Target price 65.000
Change
Ends at 25.01.23

Kursziel geändert auf 65,0

RudolfL 
0
Report Share
06.04.22
In the thread Trading Intra-Cellular Therapies Inc.
Prediction Buy
Perf. (%) 10.09%
Target price 65.000
Change
Ends at 30.01.23

Buy beendet

RudolfL 
0
Report Share
20.01.23